Epigenetic reprogramming is at the base of cancer initiation and progression. Generally, genome-wide reduction in cytosine methylation contrasts with the hypermethylation of control regions of functionally wellestablished tumor suppressor genes and many other genes whose role in cancer biology is not yet clear. While insight into mechanisms that induce aberrant cytosine methylation in cancer cells is just beginning to emerge, the initiating signals for analogous promoter methylation in plants are well documented. In Arabidopsis, the silencing of promoters requires components of the RNA interference machinery and promoter double-stranded RNA (dsRNA) to induce a repressive chromatin state that is characterized by cytosine methylation and histone deacetylation catalysed by the RPD3-type histone deacetylase AtHDA6. Similar mechanisms have been shown to occur in fission yeast and mammals. This review focuses on the connections between cytosine methylation, dsRNA and AtHDA6-controlled histone deacetylation during promoter silencing in Arabidopsis and discusses potential mechanistic similarities of these silencing events in cancer and plant cells.
Introduction
It has become increasingly clear over the past few years that both the initiation as well as the progression of many types of cancer have a strong epigenetic component. By yet poorly understood mechanisms, tumor suppressor genes can acquire de novo cytosine methylation within CpG-rich regions that are typically located around their transcriptional start sites (Jones and Laird, 1999; Baylin and Herman, 2000; Jones and Baylin, 2002) . This local epigenetic transition from DNA hypoto hypermethylation is frequently accompanied by changes in histone modifications, such as histone deacetylation and repressive histone methylation, which together result in a transcriptionally repressive chromatin state and silencing of gene expression. Usually, both alleles of a tumor suppressor gene have to be defective or inactivated for the full expression of a transformed phenotype. Thus, epigenetic silencing of one tumor suppressor allele does not result in disease, but predisposes cells to undergo malignant growth that occurs if the second allele is disabled by mutation, chromosome rearrangements resulting in loss of heterozygosity or, again, by transcriptional gene silencing via epigenetic mechanisms. The list of cancer-related genes that are affected by aberrant de novo methylation in cancer patients is growing steadily and may already outnumber reported mutation events at those genes (Jones and Baylin, 2002) . However, even some of the reported mutations might have been triggered by initial cytosine methylation. 5-methylcytosine is sensitive to hydrolytic deamination that results in a cytosine to thymine transition (Coulondre et al., 1978) . Indeed, many mutations in p53 found in cancer patients are positioned at sites of initial methylation (Rideout et al., 1990) . Since epigenetic changes are often present already before the onset of tumor progression in predisposed cells (Belinsky et al., 1998; Holst et al., 2003) , their identification provides an early diagnostic mark for cancer risk. In addition, resetting epigenetic states of silent tumor suppressor genes by nucleoside analog drugs that interfere with the maintenance of cytosine methylation and by histone deacetylase inhibitors that reverse repressive histone marks represents a rather new line of therapy for cancer patients (Cress and Seto, 2000; Jones and Baylin, 2002) .
Cancer cells undergo drastic alterations in their overall cytosine methylation pattern: genome-wide hypomethylation is contrasted with local hypermethylation in the regulatory regions of many genes whose role in cancer biology is not yet understood (Jones and Laird, 1999; Jones and Baylin, 2002; Herman and Baylin, 2003) . Recent evidence suggests that de novo methylation of at least some CpG islands in cancer cells is determined by an instructive mechanism that also operates in healthy cells Schlesinger et al., 2006; Widschwendter et al., 2007) . These regulatory regions are targeted by Polycomb complexes during development and, thus, exhibit trimethylation of lysine 27 of histone H3 (H3K27me3), a chromatin mark typical of Polycomb-mediated suppression. Importantly, although transcriptionally repressed, these genes are not associated with cytosine methylation within their CpG islands in normal tissue, but are efficiently targeted by the DNA methyltransferases (DMTs) DNMT1, DNMT3A and DNMT3B during neoplastic transformation, which results in de novo methylation . The Polycomb group protein EZH2 is a histone methyltransferase capable of methylating H3K27 and has recently been shown to interact with DNA methyltransferases both in vitro and in vivo (Muller et al., 2002; Vire´et al., 2006) . Aberrant recruitment of cytosine methylation to Polycomb target genes specifically in cancer cells might be facilitated by elevated levels of Polycomb proteins or DNA methyltransferases, respectively, which is a common feature of many tumors (De Marzo et al., 1999; Robertson et al., 1999; Varambally et al., 2002; Bracken et al., 2003) . Since most of the pre-marked genes are already transcriptionally repressed by Polycomb complexes in healthy tissue, the significance of their de novo cytosine methylation for cancer biology remains disputable .
De novo DNA methylation of regulatory regions in cancer cells is usually accompanied by deacetylation of histones H3 and H4, and the acquisition of H3K9me2, H3K9me3 as well as H3K27me3, marks typically associated with transcriptional repression (Nguyen et al., 2001; Fahrner et al., 2002; Kondo et al., 2003; McGarvey et al., 2006) Several layers of crosstalk between cytosine methylation and repressive histone modifications are evident on the molecular level. First, methylcytosine is targeted by methyl CpG-binding proteins (MBDs), which in turn can recruit transcriptional corepressors and/or chromatin remodeling proteins, histone deacetylases (HDACs) and histone methyltransferases (HMTs) (Bird and Wolffe, 1999; Wade et al., 1999; De Ruijter et al., 2003) . MBDs are conserved across kingdoms and there is evidence that a subset of them is involved in interpreting DNA methylation also in plants (Zemach and Grafi, 2007) . Second, DMTs can interact directly with either HDACs or HMTs (Fuks et al., 2001; Datta et al., 2003; Fuks et al., 2003; Li et al., 2006a) . Thus, cytosine methylation can nucleate repressive histone modifications as a primary signal, but can also be their consequence. DNA methylation provides repressive stability by 'locking in' the silent state, since inhibition of HDAC activity alone is insufficient to induce re-expression of many silenced cancer genes, but synergistically enhances effects of low doses of demethylation drugs (Cameron et al., 1999; Suzuki et al., 2002) . In addition, DNA methylation provides a heritable memory of gene repression, because it is copied during DNA replication by the maintenance enzyme DNMT1 and might serve as an initial platform for the re-establishment of the parental repressive histone code (Bestor, 2000; Rountree et al., 2000) .
While the reinforcing interplay between cytosine methylation and histone modifications is evident, little is known about the initiating signals triggering this process. A look across kingdom borders might help to develop concepts addressing this important aspect. Plant promoters can also be targeted for de novo methylation, which results in their inactivation (Wassenegger, 2000; Aufsatz et al., 2002a; Melquist and Bender, 2003; Mathieu and Bender, 2004; Cigan et al., 2005) . In contrast to the promoters of cancer genes, however, the repressive signal for this silencing of plant promoters is well established. De novo methylation is triggered by long double-stranded RNAs (dsRNAs) with sequence homology to the promoters, which are processed to 21-24 nucleotide long small RNAs by a Dicer-like activity. This RNA silencing pathway is termed RNAdirected DNA methylation (RdDM). Promoters silenced by RdDM are characterized by histone deacetylation, which in Arabidopsis is controlled by the RPD3-type histone deacetylase AtHDA6 (Aufsatz et al., 2002b) . The aim of this review is to highlight connections between cytosine methylation, dsRNA-triggered silencing and AtHDA6 during RdDM in Arabidopsis, and to potentially relate promoter silencing in plants with that occurring in cancer cells.
Arabidopsis HDACs
AtHDA6 is a member of a large gene family consisting of 16 histone deacetylases in the Arabidopsis genome (Pandey et al., 2002) . Among these, ten proteins belong to the RPD3/HDA1 superfamily: AtHDA6, AtHDA7, AtHDA9 and AtHDA19 are representatives of class I, RPD3-type HDACs. Three of the class I proteins, along with HDACs from soybean, rice and maize, further group into two branches which form clusters A (AtHDA19) and B (AtHDA6 and AtHDA7), suggesting functional specialization among these RPD3-type proteins (Pandey et al., 2002) . Specialization is supported by the phenotypes of mutant plants defective in AtHDA19 and AtHDA6, respectively. Antisense knockdown plants or stable insertion mutants of AtHda19 exhibit pleiotropic developmental phenotypes, such as early senescence, reduced apical dominance, homeotic changes, heterochronic developmental shifts and flower defects coupled with male and female sterility, thus highlighting an essential function of AtHDA19 in plant development (Tian and Chen, 2001; Tian et al., 2003) . Furthermore, AtHDA19 antagonizes the histone acetyltransferase AtGCN5 in regulating the maintenance of embryo axis formation and light-responsive gene expression, respectively (Benhamed et al., 2006; Long et al., 2006) . Besides development, AtHDA19 is required for jasmonic acid-and ethylene-mediated plant responses to plant pathogens, for responses of cultured cells to sucrose starvation and for transcriptional repression in response to abscisic acid, drought and salt stress (Song et al., 2005; Zhou et al., 2005; Nicolai et al., 2006; Song and Galbraith, 2006) . The latter response is likely executed by an AtHDA19/SIN3 repressor complex that is recruited to target genes via ethyleneresponsive element binding factors (ERFs) (Song et al., 2005; Song and Galbraith, 2006) . In contrast to AtHDA19, the role of AtHDA6 in development appears to be minor, since Athda6 mutants develop normally under standard growth conditions with the exception of slightly late flowering (Probst et al., 2004) . While knockdown of AtHDA19 causes striking global histone hyperacetylation (Tian and Chen, 2001) , Athda6 mutants show only subtle effects, indicating that AtHDA6 0 s silencing function is specialized for very specific target genes, at least under normal growth conditions (Probst et al., 2004) . In agreement with this hypothesis, endogenous regulatory functions of AtHDA6 have so far only been linked to the regulation of chromatin at recombinant DNA (rDNA) loci, where Athda6 alleles have been shown to cause decreased CpG methylation as well as localized enhanced histone acetylation (Probst et al., 2004) . Furthermore, AtHDA6 has been characterized as a broad range HDAC that is necessary for nucleolar dominance, a long-range repression of rDNA specifically from one parent in allopolyploid hybrids (Earley et al., 2006) . AtHDA5, AtHDA15 and AtHDA18 are members of the class II, HDA1-related group of HDACs. In animals, a subgroup of class II proteins possesses two tandem HDAC domains, whereas in Arabidopsis double-domain proteins are absent (Pandey et al., 2002) . Except for AtHDA18, nothing is known about the function of class II HDACs in Arabidopsis. AtHDA18 has been recently reported to control the positiondependent expression of genes involved in defining the pattern of the root epidermis (Xu et al., 2005) .
AtHDA2 represents a member of class III HDACs, which is a new group of proteins within the RPD3/ HDA1 family that involves enzymes from Drosophila (HDA403), Caenorhabditis (HDA308) and humans (HDAC11), but is absent from fungal genomes (Pandey et al., 2002) . Class III proteins are part of a cluster that also comprises bacterial acetoin utilization proteins, which provides support for a bacterial origin of class III enzymes. AtHDA8 and 14, the residual proteins of the Arabidopsis RPD3/HDA1 family, fall into the same major clade as class II proteins, but do not cluster with them. At present, the function of AtHDA2, AtHDA8 and AtHDA14 proteins is obscure.
HD2-type HDACs have only been detected in plants and are distantly related to peptidyl-prolyl cis-trans isomerases from insects, yeast and parasitic apicomplexans (Lusser et al., 1997; Aravind et al., 1998) . The Arabidopsis genome encodes four members of this family, AtHDT1-4 (Pandey et al., 2002) . AtHDT1 is required for reproductive development (Wu et al., 2000; Zhou et al., 2004) and, together with AtHDT2, for the establishment of leaf polarity, possibly by controlling the levels or distribution of two micro RNAs (miRNAs) involved in abaxial/adaxial axis formation (Ueno et al., 2007) . AtHDT1 further controls rRNA gene dosage in Arabidopsis and modulates rRNA transcription in genetic hybrids of different Arabidopsis species, which is consistent with its nucleolar localization (Lawrence et al., 2004) . AtHDT3 has recently been identified as a regulator of abiotic stress responses that are controlled by the plant stress hormone abscisic acid (Sridha and Wu, 2006) .
The last family of HDAC proteins is comprised of nucleotide adenine dinucleotide-dependent enzymes, which are called sirtuins. The founding member of this family, yeast Sir2p, controls gene silencing at telomeric, rDNA and silent-mating type loci and has further roles in cell cycle progression, DNA-damage repair and aging (Gartenberg, 2000; Guarente, 2000) . In Arabidopsis, the sirtuin family is represented by two proteins, SRT1 and 2 (Pandey et al., 2002) . Treatment of Arabidopsis plants with sirtinol, a small molecule inhibitor of sirtuins, inhibits body-axis formation and blocks the development of the vascular system (Grozinger et al., 2001) . However, these phenotypes are partially caused by sirtinol targets different from sirtuins (Zhao et al., 2003) and it remains to be determined which role the Arabidopsis SRT proteins have in these developmental processes.
AtHDA6: an intimate relationship with transcriptional RNA silencing
Among all the Arabidopsis HDACs, AtHDA6 is the only one for which a genetic and molecular connection to a distinct silencing pathway has been made. Its identification as an essential component in RdDM (Aufsatz et al., 2002b) links it to epigenetic regulation through small RNAs that trigger the covalent modification of histones and/or DNA in a sequence-specific manner (Matzke and Birchler, 2005) . These modifications result in a transcriptionally repressed state that can be stably inherited, but is still potentially reversible.
In Arabidopsis, two pathways exist that utilize small RNAs to modify chromatin. RNA interference (RNAi)-mediated heterochromatin formation refers to the targeting of repressive histone methylation to centromere sequences and other repeats by short interfering RNAs (siRNAs) and components of the RNAi machinery, such as Dicer, Argonaute (AGO) and RNAdependent RNA polymerases. This process was originally detected and extensively analysed in fission yeast (Martienssen et al., 2005; Verdel and Moazed, 2005) , and is conserved in plants, insects and vertebrates (Lippman and Martienssen, 2004; Kanellopoulou et al., 2005; Matzke and Birchler, 2005) . Importantly, heterochromatin can spread from nucleation sites initially targeted by the RNAi machinery. Small RNAs can also induce de novo cytosine methylation at sequence-homologous DNA in a process called RdDM (Wassenegger, 2000; Aufsatz et al., 2002a; Chan et al., 2004; Mathieu and Bender, 2004) . Cytosines in all sequence contexts are modified by RdDM, and methylation is restricted to the site of RNA/DNA identity, suggesting the formation of an RNA/DNA hybrid structure that is in turn recognized by the DNA methylation machinery. RdDM results in transcriptional repression when promoters are targeted (Aufsatz et al., 2002a) . Some of the proteins involved in RdDM seem to be plant-specific (see below). However, similar mechanisms apparently exist in mammalian cells, suggesting the presence of functionally related components also in mammals. Short dsRNAs or siRNAs directed against promoters in mammalian cells cause transcriptional repression, but this is not always associated with DNA methylation (Morris et al., 2004; Castanotto et al., 2005; Ting et al., 2005; Weinberg et al., 2006) . Although RNAi-mediated heterochromatin formation and RdDM have similar genetic requirements in Arabidopsis, suggesting a considerable overlap between these pathways, they can result in qualitatively distinct repressive chromatin at their targets (see below).
Endogenous siRNAs capable of epigenetically modifying the genome are typically 24 nt long in Arabidopsis. Their biogenesis and function is controlled by a specialized set of RNAi proteins, which are DICER-LIKE 3 (DCL3), the RNA-dependent RNA polymerase RDR2 and the Argonaute protein AGO4 Xie et al., 2004) . In addition, siRNA generation and function is dependent on RNA polymerase IV, which is unique to plants (Herr et al., 2005; Kanno et al., 2005; Onodera et al., 2005; Pontier et al., 2005) and a plant-specific SNF2-like protein, DRD1 (Kanno et al., 2004) . Pol IV exists as two distinct complexes in Arabidopsis, which are functionally diverse and specified by their unique largest subunits, respectively. PolIVa is required for biogenesis of siRNAs, whereas PolIVb and DRD1 act downstream of siRNAs to mediate de novo DNA methylation by a yet unknown mechanism (Kanno et al., 2005; Pontier et al., 2005) . The nuclear-acting siRNAs are processed from their long dsRNA precursors in the nucleolus, where they colocalize with the proteins mentioned above except for PolIVa subunits and DRD1. Currently, it is hypothesized that the latter proteins associate with loci that either generate precursor RNAs or that are targets for the mature siRNAs, respectively Li et al., 2006b) .
Genetic forward screens based on two-component transgene RdDM model systems in Arabidopsis, with a promoter/reporter gene as silencing target and a source of siRNAs homologous to the promoter, identified AtHDA6 as an important factor for the maintenance of the silenced state (Aufsatz et al., 2002a, b) . Mutant plants completely lacking AtHDA6 (rts1-1 mutants) exhibit transcriptional reactivation of the RdDM target promoter despite the continuous presence of the silencing-inducing RNA signal. Silencing, however, is readily re-established by backcrossing rts1-1 mutant plants to wild-type plants or by genetic complementation with wild-type AtHDA6, which suggests that histone deacetylation acts as a fast switch in repressing transcriptional activity in response to silencing RNA signals (Aufsatz et al., 2002b) . Despite the remarkable saturation of the forward genetic screens, which resulted in the recovery of 18 Athda6 alleles, AtHDA6 was the only histone-modifying enzyme identified, indicating that histone hypoacetylation might be a main characterizing feature of the chromatin of RdDM-silenced promoters. Indeed, exposure of a target promoter to the RNA signal results in deacetylation of histone H3 lysines 9 and 14, while histone marks defining constitutive heterochromatin in plants, such as H3K9me2, remain absent (Figure 1a ; compare uppermost panel to middle panel). In rts1-1 mutant plants, the target promoter is derepressed despite the continuous presence of the RNA signal and the transcriptional activity is associated with the re-acetylation of H3K9 and K14, which is in agreement with the prominent role of AtHDA6 in controlling histone deacetylation during RdDM (Figure 1a, lower panel) . Thus, in summary, neither DNA methylation nor the presence of sequencehomologous siRNAs is sufficient to convert promoters targeted by RdDM to heterochromatin, regardless of whether they represent endogenous targets or reside on integrated transgenes (Huettel et al., 2006) . This clearly discriminates promoter targets of RdDM from targets of RNAi-mediated heterochromatin formation, which in Arabidopsis are typically characterized by their association with siRNAs, cytosine hypermethylation and H3K9me2 (Lippman and Martienssen, 2004) .
AtHDA6 also has a role in RNAi-mediated heterochromatin formation. In Arabidopsis, this pathway is involved in controlling heterochromatin mainly at Figure 1 Chromatin status of targets for RNA-directed DNA methylation (a) or RNA interference-mediated heterochromatin formation (b) in wild-type (WT) or Athda6 (rts1-1) mutant plants analysed by chromatin immunoprecipitation (ChIP). ChIP was performed with antibodies specific for H3K4me3, H3K9me2, H3K27me1 and histone H3 diacetylated at lysines 9 and 14 or without antibody (-). IN, input; T, active target promoter in the absence of the RNA source; T þ S, silent (WT) or reactivated (rts1-1) target promoter in the presence of the RNA source. At4g04040 represents a control for a transcriptionally active, euchromatic gene, which is associated with the active histone mark H3K4me3.
AtHDA6 controls dsRNA-induced repressive chromatin W Aufsatz et al centromeric repeats, other repetitive elements and transposons and also at intergenic regions. However, there is redundancy with other silencing pathways that involve methyltransferase 1 (MET1), the Arabidopsis ortholog of the mammalian CpG-specific maintenance DMT DNMT1, and the chromatin remodeling ATPase DDM1 (Lippman and Martienssen, 2004) . Due to this redundancy, only a few transposons are reactivated in RNAi mutants (Lippman and Martienssen, 2004 A role for RNA in the silencing of other identified AtHDA6 targets is highly suggestive. The first alleles of AtHDA6 were identified in screens resulting in the activation of complex transgenes (Furner et al., 1998; Murfett et al., 2001) . These transgenes were characterized by either having intrinsic inverted promoter repeats or by harboring scrambled, reiterated copies of identical sequences involving promoters, which renders them a potential source for the generation of promoter dsRNA and subsequent production of promoter siRNAs. Finally, siRNAs derived from rDNA repeats have genetic properties consistent with functional siRNAs Lu et al., 2005 ; http://asrp.cgrb. oregonstate.edu/db/). The roles of these siRNAs in AtHDA6-controlled regional or long-range silencing of rDNA repeats have not been addressed so far (Probst et al., 2004; Lawrence et al., 2004; Earley et al., 2006) . In summary, compared to other Arabidopsis RPD3-type HDACs, AtHDA6 shows preponderance for the involvement in silencing processes that are likely controlled by dsRNA, which is in agreement with the proposed functional diversification within this family (Pandey et al., 2002) .
AtHDA6: a bridge between histone acetylation and DNA methylation
In many organisms, silent genes are DNA methylated and deacetylated at histones H3 and H4 (Dobosy and Selker, 2001 ). The relative importance of each modification for inducing and maintaining the repressed state and the mutual dependence of both modifications, however, are not yet clear, since they seem to vary depending on the experimental system and the repressed loci, sometimes even within a given organism. Pharmacological experiments with the HDAC inhibitor Trichostatin A (TSA) and the inhibitor of DNA methylation, 5-aza(deoxy)cytidine (5AZA) revealed, for example, that histone deacetylation and DNA methylation act synergistically to repress genes in Neurospora and in mammalian tumor cells (Selker, 1998; Momparler, 2003) . Similar findings have been reported for silent plant rDNA genes in Arabidopsis or Brassica hybrids, where application of either inhibitor results in erasure of both repressive marks and gene reactivation (Chen and Pikaard, 1997; Lawrence et al., 2004) . These reports are consistent with a model in which cytosine methylation and histone deacetylation crosstalk and are part of a self-reinforcing repressive cycle. Crosstalk between these modifications is well supported on the level of protein interactions, which indicate either direct interactions between HDACs and DMTs (Fuks et al., 2001; Datta et al., 2003) or the recruitment of HDACs to methylated DNA via MBPs (De Ruijter et al., 2003) . On the other hand, recent transcript profiling of inhibitor-treated Arabidopsis plants revealed distinct sets of up-and downregulated genes in response to TSA, 5AZA or both, and in some cases even opposite effects of the inhibitor treatments were observed (Chang and Pikaard, 2005) . Thus, DNA methylation and histone deacetylation are often intimately linked in gene silencing, but can as well act autonomously or even antagonistically.
Cytosine methylation and histone deacetylation also cooperate during silencing of promoters by RdDM. In response to dsRNA, cytosines in all sequence contexts are de novo methylated by the domain-rearranged class of de novo DMTs, DRM1 and DRM2 (Cao and Jacobsen, 2002; Cao et al., 2003) . In contrast to asymmetric cytosine methylation in a CpHpH (H is A, T or C) context, which depends on the continuous presence of the inducing signal and DRM function, methylation of symmetric cytosines in CpG or CpHpG contexts can be maintained by the plant maintenance methylation machinery even when the inducing signal is no longer present (Aufsatz et al., 2002a) . In Arabidopsis, the DNMT1 ortholog MET1 maintains CpG methylation, whereas the plant-specific chromomethylase CMT3 maintains CpHpG methylation (Chan et al., 2005) . MET1 has an additional role in CpG de novo methylation, but so far this function is restricted to methylation induced by RNA signals . In addition to cytosine methylation, the chromatin of RdDM-silenced promoters is characterized by histone deacetylation, which is controlled by AtHDA6 (see above).
Complete loss-of-function mutants for AtHDA6 exhibit reactivation of RdDM-silenced promoters, despite the continuous presence of the RNA-silencing signal. Moreover, cytosine methylation in symmetric sequence contexts, predominantly CpG methylation, is reduced, highlighting a function for AtHDA6 in maintenance methylation (Aufsatz et al., 2002b) . Although not proven yet, this function of AtHDA6 in AtHDA6 controls dsRNA-induced repressive chromatin W Aufsatz et al cytosine methylation might be mediated by the physical association with the maintenance DMTs, MET1 and CMT3. Two additional alleles of AtHDA6, rts1-3 and rts1-4, which have changes of amino acids that are invariant in RPD3-type enzymes from yeast to humans, also cause a reduction in symmetric cytosine methylation at RdDM-silenced promoters similar to the null allele (Naumann et al., manuscript in preparation). The rts1-4 mutation changes a residue involved in binding of the cofactor zinc and might, therefore, lack catalytic activity (Finnin et al., 1999) , suggesting that the functional integrity of histone deacetylase activity is important for the crosstalk with the DNA methylation machinery. The rts1-3 mutation resides within a SANTlike domain within the C-terminal part of the HDAC domain. SANT domains can mediate DNA binding as well as protein-protein interactions (Aasland et al., 1996) . Interestingly, SANT-like domains also occur in DNMT1 and the methyl CpG-binding proteins, MBD2 and MECP2 (Battaglioli et al., 2002) . Thus, it is tempting to speculate that mutations within this domain in AtHDA6 block communication with the methylation and/or methylation-readout machinery, which would be in accordance with the rts1-3 phenotype of reduced DNA methylation. However, the rts1-5 allele of AtHDA6 results in a different methylation phenotype. The corresponding mutation is located at a conserved position within the HDAC domain of AtHDA6, just N-terminal to the SANT-like domain (Naumann et al., manuscript in preparation). Mutant plants homozygous for the rts1-5 allele are characterized by strong reactivation of an RdDM-silenced target promoter, despite maintaining wild-type levels of cytosine methylation. Thus, AtHDA6 functions in transcriptional repression can be uncoupled from those required for maintenance of cytosine methylation. Moreover, the rts1-5 phenotype clearly demonstrates that DNA methylation initiated during RdDM is insufficient to induce transcriptional repression in the absence of functional AtHDA6 protein. In summary, these Athda6 alleles with very distinct effects on DNA methylation provide an excellent starting point to closer investigate the relationships between the two major repressive chromatin modifications that characterize promoters silenced by dsRNA.
Multiple ways of recruiting AtHDA6?
Although cytosine methylation alone is not sufficient to repress promoters targeted by the RdDM pathway, it still might be necessary and serve as an important signal for the recruitment of AtHDA6, which finally executes silencing. In support of this conclusion, met1 mutants fail to repress RdDM targets despite the presence of functional AtHDA6 protein (Aufsatz et al., 2002a . Since many mutant alleles of AtHDA6 affect symmetric cytosine methylation, HDAC recruitment could potentially be achieved via association with the major maintenance DMTs, MET1 and CMT3, which would be similar to the reported interactions between HDACs and DNMT1 in mammals (Fuks et al., 2000; Figure 2, top) . An alternative mechanism would be recruitment by MBD proteins, which read out CpG methylation induced by RdDM and could connect DNA methylation and corepressor complexes that contain HDAC activity (Dobosy and Selker, 2001; De Ruijter et al., 2003) . Some human MBD proteins exhibit a high sensitivity to methylated DNA in vitro and can efficiently bind to single methylated CpG sites (Bird and Wolffe, 1999) . However, in vivo, the strength of MBDmediated repression likely depends on a delicate balance between CpG methylation density and promoter strength, with a high density of CpG methylation correlating with strong and stable repression (Boyes and Bird, 1992) . The transgene target promoter in the genetic screens detecting Athda6 mutant alleles is characterized by a high number of cytosines in a CpG context, which would make it a good target for MBDmediated repression (Figure 2, top) (Aufsatz et al., 2002a, b) .
AtHDA6, however, is also involved in the repression of targets with a low CpG content. Recently, endogenous AtHDA6 controls dsRNA-induced repressive chromatin W Aufsatz et al targets of the RdDM repression pathway in Arabidopsis were identified (Huettel et al., 2006) . They are typically located in euchromatic regions of the genome and are associated with siRNA and high levels of cytosine methylation in non-CpG contexts. They are repressed in wild-type plants, where they are associated primarily with deacetylated histones, but not with H3K9me2. These targets are hypomethylated and derepressed in mutants that affect the generation or function of siRNAs, indicating that their repression in wild-type plants is under primary, potentially exclusive control of RNA silencing. One of the identified targets, a solo LTR derived from a previously uncharacterized, small Copialike retrotransposon family, was analysed for its transcriptional status in Athda6 mutant plants and found to be derepressed in all mutant alleles tested so far (Naumann and Aufsatz, unpublished results). The solo LTR harbors only two CpG sites contrasted with a multitude of CpHpH sites, which are heavily methylated in wild-type plants. The solo LTR is transcriptionally not reactivated in plants mutant for the CpG-specific DNMT MET1, suggesting that recruitment of AtHDA6 by methyl-CpG-binding proteins in this case is not relevant for silencing (Huettel et al., 2006) . One alternative possibility would be AtHDA6 recruitment by proteins that can bind to methylated cytosines in a non-CpG context (Figure 2, top) . In accordance with this hypothesis, a subset of the 13 MBD proteins of Arabidopsis has been shown to bind cytosines in a CpHpC or CpHpH context in vitro, although in some cases binding was not dependent on cytosine methylation (Zemach and Grafi, 2007) . Moreover, plant MBD proteins lack the transcriptional repressor domain (TRD) identified in their human homologs that recruits corepressor complexes. Thus, it is currently unknown by which molecular mechanism plant MBDs can actually attract HDAC activity to methylated sequences and whether they possess a yet unidentified, potentially plant-specific TRD motif. A second possibility of HDAC recruitment would be directly via the silencing RNA molecules, for example via the association of AtHDA6 with RNA binding proteins (RBP; Figure 2 , middle), by a mechanism that would act in parallel to and independent of DNA methylation. Interestingly, an extensive search for AtHDA6-interacting proteins by yeast two-hybrid analyses identified two RNA-binding proteins and an RNA helicase (Stoiber and Aufsatz, unpublished results). All three proteins are annotated to localize to the nucleolus, and thus potentially colocalize in planta with AtHDA6, for which nucleolar localization has been reported (Earley et al., 2006) , as well as with components of the processing machinery of nuclearacting siRNAs Li et al., 2006b) . Although the repression of a transgene RdDM target promoter can not be maintained in mutants affecting DNA methylation (see above), which challenges the hypothesis of methylation-independent recruitment pathways, it should be kept in mind that silencing in the two-component RdDM model system is triggered by RNA signals, which are supplied in trans. It has been reported for RNAi-mediated heterochromatin formation in fission yeast that trans-acting siRNAs that originate from centromeric repeats can target ectopic repeats, but are much less efficient than siRNAs acting in cis (Martienssen et al., 2005) . Thus, for promoters silenced by RdDM in trans, the importance of AtHDA6 recruitment by RNA signals might be minor for silencing compared to recruitment by cytosine methylation. It will be important in the future to evaluate the significance of this novel potential HDAC recruitment pathway for loci, which are both producers and targets of silencing-inducing RNA signals.
Multiple recruitment mechanisms of AtHDA6 to RNA-silenced targets might not be mutually exclusive. For example, targeting by RNAs with silencing capacity (that is, small RNAs, long dsRNA or as yet unidentified single-stranded intermediates) would provide sequencespecific HDAC recruitment before fully established DNA methylation. Later, DNA methylation might serve as a memory mark to allow continuous HDAC recruitment via MBDs (Figure 2 ).
De novo methylation of promoters in plant and cancer cells: are there common principles?
In Arabidopsis, de novo cytosine methylation and transcriptional inactivation can be clearly triggered by RNA signals. On the histone level, RNA silenced promoters are characterized by histone deacetylation rather than by repressive histone methylation. Histone deacetylation is executed by the specialized RPD3-type HDAC AtHDA6, which crosstalks with the DNA methylation machinery and 'locks in' the silenced state. Are there common underlying principles of the welldocumented hypermethylation and inactivation of plant promoters and the de novo methylation and silencing of CpG control regions during neoplastic development in various types of cancer?
Many tumor cells are characterized by the paradoxical situation in which localized hypermethylation of CpG islands is initiated in the background of global, genome-wide hypomethylation (Jones and Laird, 1999; Jones and Baylin, 2002; Herman and Baylin, 2003) . Similarly, Arabidopsis mutants that show genome-wide hypomethylation, acquire ectopic aberrant hypermethylation of certain flower-specific genes at high frequency, which can account for at least a subset of phenotypes of hypomethylation mutants (Jacobsen et al., 2000) . Interestingly, one of these genes, Superman, has been shown by genetic screens to be a potential target of RNA-instructed silencing . Peculiarities of DNA structure, such as pyrimidine richness coupled to the formation of hairpin structures, have been discussed as potential features that might attract aberrant methylation at these genes, but this does not explain why methylation is only induced in the situation of global hypomethylation. One alternative mechanism is possibly the reduction of genic CpG methylation, which occurs within transcribed sequences at an unexpectedly high frequency in Arabidopsis and has been discussed to suppress the activity of cryptic AtHDA6 controls dsRNA-induced repressive chromatin W Aufsatz et al promoters (Tran et al., 2005; Zhang et al., 2006; Zilberman et al., 2007) . Reduction of gene body methylation might result in activation of cryptic antisense promoters, whose activity would result in the formation of regional dsRNA that, in turn, could trigger aberrant de novo methylation by an RdDM-like mechanism. Depending on the location of cryptic antisense promoters, the region of dsRNA formation could encompass extreme 5 0 regions of genes, from which RNA-induced chromatin modifications might spread into proximal promoter regions. Although genome-wide analysis does not support a general correlation between loss of gene body methylation and antisense transcription, such a mechanism could be effective, however, for a limited number of genes (Zhang et al., 2006) , which is supported by the existence of several 'hot-spots' for hypermethylation in hypomethylated Arabidopsis genomic backgrounds (Jacobsen et al., 2000) . Since vertebrate genes are also characterized by extensive gene body methylation (Goll and Bestor, 2005; Klose and Bird, 2006) , similar mechanisms could potentially apply for genes that are hypermethylated in cancer cells. In mammalian cells, a mechanistic link between siRNAs directed to promoters and induction of cytosine methylation has been convincingly demonstrated, which supports the basic existence of RdDMlike processes also in mammals (Morris et al., 2004; Castanotto et al., 2005) . The existence of cancer cell or tumor-specific dsRNA is supported by a recent publication, which reports on natural antisense transcripts that are differentially expressed in various tumors (Klimov et al., 2006) . In mammals, however, long dsRNA induces an antiviral response mediated by interferon, which results in a general inhibition of protein synthesis and nonspecific degradation of mRNA (Kawai and Akira, 2006) . The interferon pathway usually impedes gene-specific silencing induced by long dsRNA in most mammalian cell types. Thus, in order to trigger specific silencing effects, dsRNAs generated by cancer cellspecific antisense transcription have either to be sufficiently short to avoid induction of the interferon response or are effective only in cancer cell types with a compromised or absent interferon response (Billy et al., 2001) , which would limit the conditions for such an RNA-instructed de novo methylation pathway. RNA signals, however, might only be one of multiple signals that induce cancer-specific aberrant cytosine methylation, since Polycomb-mediated silencing has recently been reported to premark many genes that acquire methylation during neoplastic transformation Schlesinger et al., 2006; Widschwendter et al., 2007) . There is emerging evidence of connections between Polycomb silencing and RNAi (Grimaud et al., 2006; Kim et al., 2006) , indicating that dsRNA might be at the basis of multiple pathways that can potentially result in ectopic DNA methylation in cancer development. However, siRNAs directed to promoter sequences in cancer cells can also induce transcriptional gene silencing and repressive chromatin in the absence of cytosine methylation, which provides evidence for an RNA-triggered recruitment of histone-modifying enzymes, such as HDACs and HMTs, in mammalian cells (Ting et al., 2005) . In summary, the analysis of relationships between dsRNA signals, cytosine methylation and recruitment of histone-modifying enzymes in well-characterized plant model silencing systems has potential implications that extend far beyond the plant field. It might assist in detecting mechanisms involved in reprogramming epigenetic states during cancer initiation and development.
Conclusions and perspectives
Plant silencing systems clearly demonstrate that promoters can be inactivated by sequence-homologous dsRNA. Promoter inactivation is associated with de novo cytosine methylation and histone deacetylation. There is emerging evidence that histone deacetylation can be triggered either in response to dsRNA-induced cytosine methylation or directly instructed by dsRNA. Cancer cells exhibit analogous reprogramming of promoter activity associated with cytosine hypermethylation and the acquisition of repressive histone modifications. Recent evidence suggests that one mechanism to recruit aberrant DNA methylation involves crosstalk between Polycomb-silencing complexes and DNA methyltransferases. The significance of this de novo methylation pathway for cancer biology, however, is still unclear. Many of its target genes are already silenced by Polycomb proteins in healthy precursor cells, indicating that their encoded proteins are likely not important for the protection of cells against neoplastic transformation. This knowledge about alternative mechanisms from plant models might assist in the detection of control regions of validated or candidate tumor suppressor genes, which change epigenetic states in the transition from healthy to cancer cells. It is likely that, analogous to the situation in plants, this transition is triggered by dsRNA and components of the RNAi machinery. Specific dsRNAs could potentially arise as a consequence of enhanced cancer-specific antisense transcription due to the activation of cryptic promoters by the genome-wide loss of cytosine methylation typically associated with cancer initiation. Thus, it will be important to carefully analyse hypermethylated target genes in cancer cells for evidence of antisense transcription and to explore whether the initiation and/or maintenance of the hypermethylated state requires the integrity of the RNAi pathway. Since plants can potentially recruit HDACs directly via RNA signals and mammals can silence promoters by siRNAs and/or dsRNA without concomitant DNA methylation, RNAbased gene silencing in cancer cells might not always be accompanied by hypermethylation. Thus, many consequences of misregulated RNA silencing pathways in cancer cells might have gone unnoticed so far.
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